Business
Cipher Pharmaceuticals to Present at Two Upcoming U.S. Investor Conferences
Cipher Pharmaceuticals to Present at Two Upcoming U.S. Investor Conferences Cipher...
About this update from Cipher Pharmaceuticals Inc.
[{"type":"text","content":"\n\n\n\nCipher Pharmaceuticals to Present at Two Upcoming U.S. Investor Conferences\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nCipher Pharmaceuticals to Present at Two Upcoming U.S. Investor Conferences\nCanada NewsWire\nMISSISSAUGA, ON, May 31, 2016\n\n\n\nMISSISSAUGA, ON, May 31, 2016 /CNW/ - Cipher Pharmaceuticals Inc. (NASDAQ:CPHR; TSX:CPH) (\"Cipher\" or \"the Company\") today announced that Shawn Patrick O'Brien, President and Chief Executive Officer, will present at two upcoming investor conferences. \n\n\nJefferies 2016 Healthcare Conference in New York on June 10 at 8:30 a.m. ET. \nJMP Securities 2016 Life Sciences Conference in New York on June 22 at 2:00 p.m. ET.\n\nBoth conference presentations will be webcast live. To access the webcasts, please go to the Investors section of Cipher's website at www.cipherpharma.com under the Events and Webcasts tab. \n\nAbout Cipher Pharmaceuticals Inc.Cipher Pharmaceuticals (NASDAQ:CPHR; TSX:CPH) is a rapidly growing specialty pharmaceutical dermatology company with a diversified portfolio of commercial-stage products with the goal of becoming the most customer-centric dermatology company in North America.\n\nCipher completed seven transactions in 2015, including the acquisition of Innocutis and its nine branded dermatology products, to build its U.S. commercial presence, expand its Canadian dermatology franchise and broaden its pipeline. Cipher is well-capitalized to drive long-term, sustained earnings growth by leveraging its proven clinical development capabilities and efficient commercial execution. For more information, visit www.cipherpharma.com.\nSOURCE Cipher Pharmaceuticals Inc.\n\n\n\n\n\n\nInvestors: In Canada: Craig Armitage, LodeRock Advisors, (416) 347-8954, [email protected]; In the United States: Thomas Hoffmann, The Trout Group LLC, (646) 378-2931, [email protected]; Media: Mike Beyer, Sam Brown Inc., (312) 961-2502, [email protected] CNW Group 2016","length":3356,"tagName":"div"}]